1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 35460066 | Effectiveness of eribulin as first-line or second-line chemotherapy for HER2-negative hormone-resistant advanced or metastatic breast cancer: findings from the multi-institutional, prospective, observational KBCRN A001: E-SPEC study. | 2022 Apr 23 | 2 |